Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Nutritional support in patients with GVHD of the digestive tract: state of the art

Abstract

An important complication of allo-SCT is GVHD, which commonly affects the skin, liver and digestive tract. Clinical symptoms of GVHD of the digestive tract (GVHD-DT) include excessive diarrhoea, abdominal pain and cramps, nausea and vomiting, gastrointestinal bleeding, dysphagia, and weight loss. Treatment is complicated and regarding nutritional support, only a few guidelines are available. Our aim was to critically appraise the literature on nutritional assessment, nutritional status and nutritional support for patients with GVHD-DT. Evidence shows that GVHD-DT is often associated with malnutrition, protein losing enteropathy, magnesium derangements, and deficiencies of zinc, vitamin B12 and vitamin D. Limited evidence exists on derangements of magnesium, resting energy expenditure, bone mineral density and pancreatic function, and some beneficial effects of n-3 polyunsaturated fatty acids and pancreatic enzyme replacement therapy. Expert opinions recommend adequate amounts of energy, at least 1.5 g protein/kg body weight, supplied by total parenteral nutrition in cases of severe diarrhoea. When diarrhoea is <500 mL a day, a stepwise oral upgrade diet can be followed. No studies exist on probiotics, prebiotics, dietary fibre and immunonutrition in GVHD-DT patients. Future research should focus on absorption capacity, vitamin and mineral status, and nutritional support strategies.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Iqbal N, Salzman D, Lazenby AJ, Wilcox CM . Diagnosis of gastrointestinal graft-versus-host disease. Am J Gastroenterol 2000; 95: 3034–3038.

    Article  CAS  PubMed  Google Scholar 

  2. Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V et al. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant 2003; 9: 46–51.

    Article  PubMed  Google Scholar 

  3. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  4. Martin PJ, McDonald GB, Sanders JE, Anasetti C, Appelbaum FR, Deeg HJ et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004; 10: 320–327.

    Article  PubMed  Google Scholar 

  5. Holler E . Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment. Best Pract Res Clin Haematol 2007; 20: 281–294.

    Article  CAS  PubMed  Google Scholar 

  6. Roberts S, Thompson J . Graft-vs-Host Disease: nutrition therapy in a challenging condition. Nutr Clin Pract 2005; 20: 440–450.

    Article  PubMed  Google Scholar 

  7. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.

    Article  CAS  PubMed  Google Scholar 

  8. Oxford Centre for Evidence-Based Medicine. 2011 Levels of Evidence. www.cebmnet/indexaspx?o=55132012.

  9. Sauerwein HP, Serlie MJ . Optimal nutrition and its potential effect on survival in critically ill patients. Neth J Med 2010; 68: 119–122.

    CAS  PubMed  Google Scholar 

  10. Lenssen P, Sherry ME, Cheney CL, Nims JW, Sullivan KM, Stern JM et al. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 1990; 90: 835–842.

    CAS  PubMed  Google Scholar 

  11. Papadopoulou A, Lloyd DR, Williams MD, Darbyshire PJ, Booth IW . Gastrointestinal and nutritional sequelae of bone marrow transplantation. Arch Dis Child 1996; 75: 208–213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kyle UG, Chalandon Y, Miralbell R, Karsegard VL, Hans D, Trombetti A et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients. Bone Marrow Transplant 2005; 35: 1171–1177.

    Article  CAS  PubMed  Google Scholar 

  13. Jacobsohn DA, Margolis J, Doherty J, Anders V, Vogelsang GB . Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 231–236.

    Article  CAS  PubMed  Google Scholar 

  14. Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P et al. Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 2006; 38: 299–303.

    Article  CAS  PubMed  Google Scholar 

  15. Browning B, Thormann K, Seshadri R, Duerst R, Kletzel M, Jacobsohn DA . Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease. Bone Marrow Transplant 2006; 37: 527–533.

    Article  CAS  PubMed  Google Scholar 

  16. Zauner C, Rabitsch W, Schneeweiss B, Schiefermeier M, Greinix HT, Keil F et al. Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease. Transplantation 2001; 71: 524–528.

    Article  CAS  PubMed  Google Scholar 

  17. Imataki O, Nakatani S, Hasegawa T, Kondo M, Ichihashi K, Araki M et al. Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Am J Hematol 2006; 81: 747–752.

    Article  PubMed  Google Scholar 

  18. Williams M . Gastrointestinal manifestations of graft-versus-host disease: diagnosis and management. AACN Clin Issues 1999; 10: 500–506.

    Article  CAS  PubMed  Google Scholar 

  19. Flowers ME, McDonald G, Carpenter P, Boeckh M, Sanders J, Deeg J et al. Long-term follow-up after hematopoietic stem cell transplant; general guidelines for referring physicians. Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Version 4 August 2008, pp 1–78.

  20. Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990; 76: 624–629.

    CAS  PubMed  Google Scholar 

  21. Akpek G, Valladares JL, Lee L, Margolis J, Vogelsang GB . Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2001; 27: 163–166.

    Article  CAS  PubMed  Google Scholar 

  22. Seemayer TA, Gartner JG, Colle E, Lapp WS . Acute graft-versus-host reaction in the pancreas. Transplantation 1983; 35: 72–77.

    Article  CAS  PubMed  Google Scholar 

  23. Nakamura N . A clinicopathological study of 15 autopsy cases with allogeneic bone marrow transplantation in special reference to graft versus host disease (GVHD). Acta Pathol Jpn 1986; 36: 641–664.

    CAS  PubMed  Google Scholar 

  24. Foulis AK, Farquharson MA, Sale GE . The pancreas in acute graft versus host disease in man. Histopathology 1989; 14: 121–128.

    Article  CAS  PubMed  Google Scholar 

  25. Maringhini A, Gertz MA, DiMagno EP . Exocrine pancreatic insufficiency after allogeneic bone marrow transplantation. Int J Pancreatol 1995; 17: 243–247.

    CAS  PubMed  Google Scholar 

  26. Fine KD, Fordtran JS . The effect of diarrhea on fecal fat excretion. Gastroenterology 1992; 102: 1936–1939.

    Article  CAS  PubMed  Google Scholar 

  27. Grigg AP, Angus PW, Hoyt R, Szer J . The incidence, pathogenesis and natural history of steatorrhea after bone marrow transplantation. Bone Marrow Transplant 2003; 31: 701–703.

    Article  CAS  PubMed  Google Scholar 

  28. Nakasone H, Ito A, Endo H, Kida M, Koji I, Usuki K . Pancreatic atrophy is associated with gastrointestinal chronic GVHD following allogeneic PBSC transplantation. Bone Marrow Transplant 2010; 45: 590–592.

    Article  CAS  PubMed  Google Scholar 

  29. Imrie CW, Connett G, Hall RI, Charnley RM . Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther 2010; 32 (Suppl 1): 1–25.

    Article  CAS  PubMed  Google Scholar 

  30. Anderson H, Grimes DS, Morgenstern AR, Scarffe JH . Pancreatic insufficiency after bone-marrow transplantation. Lancet 1991; 338: 1088–1089.

    Google Scholar 

  31. Jurges E, el TM, O'Donohue J, Hobbs J . Pancreatic insufficiency after bone-marrow transplantation. Lancet 1991; 338: 517.

    Article  CAS  PubMed  Google Scholar 

  32. Windmueller HG, Spaeth AE . Source and fate of circulating citrulline. Am J Physiol 1981; 241: E473–E480.

    CAS  PubMed  Google Scholar 

  33. Wakabayashi Y, Jones ME . Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. J Biol Chem 1983; 258: 3865–3872.

    CAS  PubMed  Google Scholar 

  34. Wu G . Intestinal mucosal amino acid catabolism. J Nutr 1998; 128: 1249–1252.

    Article  CAS  PubMed  Google Scholar 

  35. van der Velden WJ, Herbers AH, Feuth T, Schaap NP, Donnelly JP, Blijlevens NM . Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS One 2010; 5: e15156.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE . Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Nat Rev Cancer 2005; 103: 191–199.

    Google Scholar 

  37. Rzepecki P, Barzal J, Oborska S . Blood and marrow transplantation and nutritional support. Support Care Cancer 2010; 18 (Suppl 2): S57–S65.

    Article  PubMed  Google Scholar 

  38. Murray SM, Pindoria S . Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2002; 2: CD002920.

    Google Scholar 

  39. Murray SM, Pindoria S . Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2009; 1: CD002920.

    Google Scholar 

  40. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW . Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309–3316.

    CAS  PubMed  Google Scholar 

  41. Seguy D, Berthon C, Micol JB, Darre S, Dalle JH, Neuville S et al. Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning. Transplantation 2006; 82: 835–839.

    Article  PubMed  Google Scholar 

  42. Svahn BM, Remberger M, Heijbel M, Martell E, Wikstrom M, Eriksson B et al. Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation 2008; 85: 1000–1007.

    Article  PubMed  Google Scholar 

  43. Martin-Salces M, de PR, Canales MA, Mesejo A, Hernandez-Navarro F . Nutritional recommendations in hematopoietic stem cell transplantation. Nutrition 2008; 24: 769–775.

    Article  CAS  PubMed  Google Scholar 

  44. Kreymann G, Adolph M, Mueller MJ . Energy expenditure and energy intake—Guidelines on Parenteral Nutrition, Chapter 3. Ger Med Sci 2009 7: Doc25.

  45. Dempsey DT, Feurer ID, Knox LS, Crosby LO, Buzby GP, Mullen JL . Energy expenditure in malnourished gastrointestinal cancer patients. Nat Rev Cancer 1984; 53: 1265–1273.

    CAS  Google Scholar 

  46. Forchielli ML, Azzi N, Cadranel S, Paolucci G . Total parenteral nutrition in bone marrow transplant: what is the appropriate energy level? Oncology 2003; 64: 7–13.

    Article  CAS  PubMed  Google Scholar 

  47. Muscaritoli M, Grieco G, Capria S, Iori AP, Rossi FF . Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 2002; 75: 183–190.

    Article  CAS  PubMed  Google Scholar 

  48. FAO/WHO/UNU. Energy and protein requirementsGeneva: WHO Technical Report Series; 1985.

  49. Weisdorf SA, Salati LM, Longsdorf JA, Ramsay NK, Sharp HL . Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin. Gastroenterology 1983; 85: 1076–1081.

    CAS  PubMed  Google Scholar 

  50. Savani BN, Donohue T, Kozanas E, Shenoy A, Singh AK, Childs RW et al. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 517–520.

    Article  PubMed  Google Scholar 

  51. Stern JM, Chesnut CH, Bruemmer B, Sullivan KM, Lenssen PS, Aker SN et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 1996; 17: 395–400.

    CAS  PubMed  Google Scholar 

  52. Duncan CN, Vrooman L, Apfelbaum EM, Whitley K, Bechard L, Lehmann LE . 25-Hydroxy vitamin D deficiency following pediatric hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2011; 17: 749–753.

    Article  CAS  PubMed  Google Scholar 

  53. Kreutz M, Eissner G, Hahn J, Andreesen R, Drobnik W, Holler E . Variations in 1 alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 871–873.

    Article  CAS  PubMed  Google Scholar 

  54. Sanders JE . Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol 2002; 76 (Suppl 2): 15–28.

    Article  PubMed  Google Scholar 

  55. Carpenter PA, Hoffmeister P, Chesnut CH, Storer B, Charuhas PM, Woolfrey AE et al. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007; 13: 683–690.

    Article  CAS  PubMed  Google Scholar 

  56. Milligan DW, Quick A, Barnard DL . Vitamin B12 absorption after allogeneic bone marrow transplantation. J Clin Pathol 1987; 40: 1472–1474.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P . Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30: 785–792.

    Article  CAS  PubMed  Google Scholar 

  58. Kelly P, Feakins R, Domizio P, Murphy J, Bevins C, Wilson J et al. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol 2004; 135: 303–309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Ripamonti C, Fulfaro F . Taste alterations in cancer patients. J Pain Symptom Manage 1998; 16: 349–351.

    Article  CAS  PubMed  Google Scholar 

  60. Ripamonti C, Zecca E, Brunelli C, Fulfaro F, Villa S, Balzarini A et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Nat Rev Cancer 1998; 82: 1938–1945.

    CAS  Google Scholar 

  61. Boltong A, Keast R . The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 2012; 38: 152–163.

    Article  CAS  PubMed  Google Scholar 

  62. Majhail NS, DeFor TE, Lazarus HM, Burns LJ . Iron-overload after autologous hematopoietic cell transplantation. Leuk Res 2009; 33: 578–579.

    Article  CAS  PubMed  Google Scholar 

  63. Majhail NS, Lazarus HM, Burns LJ . Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 2008; 41: 997–1003.

    Article  CAS  PubMed  Google Scholar 

  64. Marik PE, Zaloga GP . Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008; 34: 1980–1990.

    Article  PubMed  Google Scholar 

  65. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujimori Y et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419–426.

    Article  CAS  PubMed  Google Scholar 

  66. Takatsuka H, Iwasaki T, Okamoto T, Kakishita E . Intestinal graft-versus-host disease: mechanisms and management. Drugs 2003; 63: 1–15.

    Article  CAS  PubMed  Google Scholar 

  67. Takatsuka H, Takemoto Y, Iwata N, Suehiro A, Hamano T, Okamoto T et al. Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 2001; 28: 769–774.

    Article  CAS  PubMed  Google Scholar 

  68. Takatsuka H, Takemoto Y, Yamada S, Wakae T, Mori A, Okada M et al. Oral eicosapentaenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation. Drugs Exptl Clin Res 2002; 18: 121–125.

    Google Scholar 

  69. Noe JE . L-glutamine use in the treatment and prevention of mucositis and cachexia: a naturopathic perspective. Integr Cancer Ther 2009; 8: 409–415.

    Article  CAS  PubMed  Google Scholar 

  70. Crowther M, Avenell A, Culligan DJ . Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant 2009; 44: 413–425.

    Article  CAS  PubMed  Google Scholar 

  71. Santora R, Kozar RA . Molecular mechanisms of pharmaconutrients. J Surg Res 2010; 161: 288–294.

    Article  CAS  PubMed  Google Scholar 

  72. Coeffier M, Dechelotte P . Combined infusion of glutamine and arginine: does it make sense? Curr Opin Clin Nutr Metab Care 2010; 13: 70–74.

    Article  CAS  PubMed  Google Scholar 

  73. Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010; 116: 5738–5747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Ellison CA, Natuik SA, McIntosh AR, Scully SA, Danilenko DM, Gartner JG . The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice. Immunology 2003; 109: 440–449.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Garside P, Hutton AK, Severn A, Liew FY, Mowat AM . Nitric oxide mediates intestinal pathology in graft-vs-host disease. Eur J Immunol 1992; 22: 2141–2145.

    Article  CAS  PubMed  Google Scholar 

  76. Quigley EM . Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res 2010; 61: 213–218.

    Article  PubMed  Google Scholar 

  77. Isolauri E, Kirjavainen PV, Salminen S . Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002; 50: III54–III59.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Gerbitz A, Schultz M, Wilke A, Linde HJ, Scholmerich J, Andreesen R et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 2004; 103: 4365–4367.

    Article  CAS  PubMed  Google Scholar 

  79. Rajendran N, Kumar D . Role of diet in the management of inflammatory bowel disease. World J Gastroenterol 2010; 16: 1442–1448.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Jaing TH, Hung IJ, Chung HT, Lai CH, Liu WM, Chang KW . Acute hypermagnesemia: a rare complication of antacid administration after bone marrow transplantation. Clin Chim Acta 2002; 326: 201–203.

    Article  CAS  PubMed  Google Scholar 

  81. Leong DP, Kleinig TJ, Kimber TE, Bardy PG . Severe hypermagnesaemia related to laxative use in acute gastrointestinal graft-versus-host disease. Bone Marrow Transplant 2006; 38: 71–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Marieke CE Schoordijk (MANP) for sharing her experience and reviewing the conceptual article, and Kelly Duin for carrying out data collection and explorative literature research during her Master fellowship in VU Health and Sciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B S van der Meij.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Meij, B., de Graaf, P., Wierdsma, N. et al. Nutritional support in patients with GVHD of the digestive tract: state of the art. Bone Marrow Transplant 48, 474–482 (2013). https://doi.org/10.1038/bmt.2012.124

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.124

Keywords

This article is cited by

Search

Quick links